Issuer · CIK 0001601830
RXRX — RECURSION PHARMACEUTICALS, INC.
Recent filings
- Jun 22, 2026·Form 4·Pro · in 10h 35m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
Borgeson Blake · director
Proonly - Jun 22, 2026·Form 4·Pro · in 10h 35m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
HERSHBERG ROBERT · director
Proonly - Jun 22, 2026·Form 4·Pro · in 10h 35m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
Michor Franziska · director
Proonly - Jun 22, 2026·Form 4·Pro · in 10h 35m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
Sun Elaine D · director
Proonly - Jun 22, 2026·Form 4·Pro · in 10h 34m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
Dar Zavain · director
Proonly - Jun 22, 2026·Form 4·Pro · in 10h 34m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
Li Dean Y · director
Proonly - Jun 22, 2026·Form 4·Pro · in 10h 34m$•••K
RXRX/RECURSION PHARMACEUTICALS, INC.
Bumpus Namandje · director
Proonly - Jun 17, 2026·Form 4·Other$17K
RXRX/RECURSION PHARMACEUTICALS, INC.
Taylor Ben R · Chief Financial Officer
Mechanical filing
AI thesis skipped - Jun 5, 2026·Form 4·Sell$144.8K
RXRX/RECURSION PHARMACEUTICALS, INC.
Gibson Christopher · director
Mechanical filing
AI thesis skipped - Jun 5, 2026·Form 4·Sell$84.5K
RXRX/RECURSION PHARMACEUTICALS, INC.
Khan Najat · CEO and President
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Sell$15.5K
RXRX/RECURSION PHARMACEUTICALS, INC.
Bumpus Namandje · director
Mechanical filing
AI thesis skipped - Jun 4, 2026·Form 4·Sell$110.4K
RXRX/RECURSION PHARMACEUTICALS, INC.
Borgeson Blake · director
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Other$81K
RXRX/RECURSION PHARMACEUTICALS, INC.
Hallett David · Chief Scientific Officer
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Other$190.6K
RXRX/RECURSION PHARMACEUTICALS, INC.
Khan Najat · CEO and President
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Other$76.1K
RXRX/RECURSION PHARMACEUTICALS, INC.
Taylor Ben R · Chief Financial Officer
Mechanical filing
AI thesis skipped - May 19, 2026·Form 4·Other$69.4K
RXRX/RECURSION PHARMACEUTICALS, INC.
Gibson Christopher · director
Mechanical filing
AI thesis skipped - May 8, 2026·Form 4·Sell$134.8K
RXRX/RECURSION PHARMACEUTICALS, INC.
Gibson Christopher · director
14conviction - May 7, 2026·Form 4·Sell$105.6K
RXRX/RECURSION PHARMACEUTICALS, INC.
Borgeson Blake · director
22conviction